Industry Insights

  1. From Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development 3/4/2026

    Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

  2. Kicking Off 2026 With New Health Policy Priorities 3/4/2026

    See late‑2025 policy actions, including international pricing agreements, new payment models, and global regulatory changes, while previewing key themes expected to shape 2026 health policy.

  3. 5 Trends To Watch This Year 3/4/2026

    Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

  4. How Regional Logistics Strategy Supports Clinical Success In Europe 3/4/2026

    In an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.

  5. FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs 3/4/2026

    The FDA draft guidance on Bayesian methodology represents a major validation of statistical innovation in clinical development. Jessica Cordes summarizes the latest from the FDA and offers advice for small biotechs.

  6. Adapt Or Die: Best Practices In Designing An Adaptive, Open-Label RCT Phase 3 Oncology Trial 3/3/2026

    Discover how adaptive trial design can deliver greater operational efficiency, improved efficacy outcomes, and enhanced sponsor affordability across the drug development life cycle.

  7. The Uncomfortable Conversation: AI And Data Use In Clinical Trials 3/2/2026

    AI is quietly transforming clinical trials at the site level, boosting efficiency while creating hidden risks for patient data, protocols, and sponsor intellectual property.

  8. When A Clinical Trial Surfaces In An AI Chat, What Happens Next? 3/2/2026

    AI is soon becoming the first interpreter of your clinical trial. Understand its implications for enrollment design, screening efficiency, and ultimately program predictability.

  9. The Innovations Shaping 2026 CNS Clinical Trials 2/27/2026

    Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

  10. The Cost Of Transactional Thinking In Clinical Research 2/26/2026

    Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.